Tag

Ibogaine

All articles tagged with #ibogaine

Wealthy Americans Pay Up to $20,000 for Risky Ibogaine Retreats in Mexico
health6 days ago

Wealthy Americans Pay Up to $20,000 for Risky Ibogaine Retreats in Mexico

High-earning Americans are traveling to Mexico to pay up to $20,000 for ibogaine treatments, seeking relief from addiction, burnout, or performance issues despite significant cardiac risks. Clinics in Cancun and Playa del Carmen offer luxury retreats with medical supervision, though the drug remains illegal in the U.S. outside clinical trials. The trend gained attention after the death of Presley Gerber, who had undergone similar high-dose treatments. Experts warn that these unregulated therapies lack consistent safety standards and are not proven cures for substance use disorders.

Experts Link Presley Gerber’s Death to Unproven Ibogaine Therapy and Patient-Directed Care
health18 days ago

Experts Link Presley Gerber’s Death to Unproven Ibogaine Therapy and Patient-Directed Care

Presley Gerber, 27, died at a Santa Monica rehabilitation facility on September 20, 2026, with authorities investigating the incident as a suspected overdose. While final toxicology results are pending, addiction specialist Dr. Drew Pinsky cited Gerber’s prior use of ibogaine in Mexico as a critical red flag. Pinsky argued that allowing patients to dictate their own care, particularly by seeking unapproved alternative therapies, often leads to relapse and fatal outcomes. CNN provided context on ibogaine, a Schedule I substance derived from an African shrub, noting that while it is being studied for addiction and mental health, it carries significant cardiac risks and remains illegal in the U.S. outside of clinical trials.

Presley Gerber’s Open Fight With Addiction Precedes Tragic Death at 27
entertainment19 days ago

Presley Gerber’s Open Fight With Addiction Precedes Tragic Death at 27

Presley Gerber, 27, son of Cindy Crawford and Rande Gerber, died in a rehabilitation facility with Santa Monica police investigating the death as a suspected overdose. In the months before his death he publicly documented his battle with addiction and mental health, including a March post about undergoing ibogaine treatment in Mexico. His family publicly supported his recovery efforts, and his sister Kaia and parents spoke about privacy and pride as the investigation continues. The medical examiner has deferred the official cause of death, and authorities have not released further details.

Kevin Sheard, 34, Remembered for Compassion, Travel, and Psychedelic Medicine
obituaries4 months ago

Kevin Sheard, 34, Remembered for Compassion, Travel, and Psychedelic Medicine

Kevin Charles Sheard, 34, of Avon Lake, Ohio, died May 28, 2026. He worked in fiber optics in Fort Lauderdale and pursued broad cultural and spiritual interests, earning certifications in Ibogaine and Kambo and founding Kambo Essence to aid PTSD and trauma. A MAPS member, he loved hiking, his dog Pedro, Browns games, and his church communities at Vine Church and Avon Lake UCC. Memorial gifts are suggested to Vine Church or Avon Lake UCC.

Trump Signs Order to Fast-Track Psychedelic Therapies for Veterans
politics5 months ago

Trump Signs Order to Fast-Track Psychedelic Therapies for Veterans

President Trump signed an executive order to accelerate research and access to psychedelic medicines—highlighting ibogaine—as potential treatments for serious mental illnesses and focusing on veterans with PTSD and suicide risk. The order directs cross‑agency collaboration (DOJ, HHS, VA, FDA), aims for faster regulatory review through science‑based pathways, and includes a $50 million federal funding commitment for ibogaine research and expanded access in licensed, hospital‑grade settings, all while maintaining rigorous safety standards.

Trump signs order to fast-track psychedelic research, including ibogaine
politics5 months ago

Trump signs order to fast-track psychedelic research, including ibogaine

President Trump signed an executive order to ease federal restrictions on psychedelic research, including ibogaine, with a $50 million funding commitment and a pathway for ibogaine to be studied and used under the FDA's Right To Try for seriously ill patients. The FDA will also add three psychedelics to the National Priority Voucher program to accelerate reviews, while maintaining oversight and not legalizing the drugs. The move aims to spur new mental-health treatments but underscores safety concerns and the need for more robust clinical trials.

White House eyes ibogaine research funding for PTSD
politics5 months ago

White House eyes ibogaine research funding for PTSD

The White House is drafting an executive order to open the door to federal funding for research on ibogaine, a psychedelic used abroad to treat PTSD and brain injuries. It would not reclassify the drug (still Schedule I) but signals support for further U.S. studies on safety and effectiveness, with a focus on veterans. Evidence is limited—mostly small observational studies—with notable cardiac risks and several deaths reported; a Stanford study suggested potential PTSD relief when ibogaine is paired with magnesium, yet more rigorous trials are needed before any medical use.

NFL and UFC Athletes Explore Psychedelics for Brain Injury Recovery
health1 year ago

NFL and UFC Athletes Explore Psychedelics for Brain Injury Recovery

A small but growing number of athletes and veterans are turning to ibogaine, a psychedelic derived from a West African shrub, for potential treatment of traumatic brain injury, PTSD, and addiction. While promising results from studies and personal testimonies suggest significant benefits, experts caution that more research and clinical trials are needed due to safety concerns and legal restrictions. The treatment is currently unregulated in the U.S., but interest and funding for further research are increasing.

Exploring Navy SEALS' Battle with PTSD and Psychedelic Therapy
health1 year ago

Exploring Navy SEALS' Battle with PTSD and Psychedelic Therapy

The documentary 'In Waves and War' explores the struggles of Navy SEALS with PTSD, addiction, and other mental health issues following deployments to Iraq and Afghanistan. It highlights the potential of psychedelic treatments like ibogaine and 5-MeO-DMT, which some veterans have found beneficial despite regulatory challenges in the U.S. The film underscores the mental health crisis among veterans and the need for alternative therapies.